Clinical Trial Update: Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated docetaxel and gemcitabine with Filgrastim-SD/01 support in patients with advanced non-small cell lung cancer; the study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Filgrastim-SD/01 (filgrastim)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Schwartzberg, Lee, M.D. | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED